Obama's precision medicine initiative looks set for bipartisan support, Valeant has offered $296 million to buy Dendreon and researchers say Roche's Tamiflu works.
You've seen the ads touting a "Day of Disruption." Here's the scoop on MM&M's first ever Transforming Healthcare conference.
Shane Mayer, VP, client services at InTouch Solutions
Cindy Whitehead, CEO, Sprout Pharmaceuticals
Researchers found that 25% of ACA-compliant plans put HIV drugs in the highest formulary tier.
Alexion's CEO Leonard Bell is retiring, and TripAdvisor's Christine Peterson has joined Treato.
The label will now include Waldenstrom's macroglubulinemia.
Former FDA chief tells court J&J knew of Risperdal risk, pay-for-delay deals get new court criteria, lawmakers may declare pharmacists healthcare providers.
MS drugmaker Biogen Idec drafted Tyler Campbell, son of NFL Hall of Fame running back Earl Campbell, and former Dallas Mavericks point guard Chris Wright to help inspire sufferers of multiple sclerosis.
Amgen execs assert there is still a future for 15-year-old Enbrel, Novartis sees off-label Avastin use pinch Lucentis sales and BMS has expanded its field force in anticipation of an Opdivo push.
This compelling e-book shares a wealth of insights designed to help members of sales forces connect with elusive HCPs. An expanded version has also been created that includes video interviews and other multimedia content. Click here for access.